resistance mechanisms in aml and treatment decisions
Published 5 years ago • 100 plays • Length 4:15Download video MP4
Download video MP3
Similar videos
-
3:42
mechanisms of resistance to venetoclax in aml and methods being explored to overcome these
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
2:30
what is the patient’s role in making aml treatment decisions?
-
4:33
maintenance and continuous treatment in acute myeloid leukemia
-
18:29
aml treatment challenges who, when, and how
-
3:18
what is blood cancer?
-
3:12
my cbc blood count numbers / cml / chronic myeloid leukemia / cml blood test results
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
9:40
acute myeloid leukemia outcomes
-
2:38
primary and secondary resistance in aml
-
13:36
aml on the go - bcl-2 inhibition in acute myeloid leukemia
-
1:48
dr. ravandi on resistance in aml
-
52:20
acute myeloid leukemia: incorporating novel treatment approaches into clinical pathways
-
6:43
flt3 mutations’ impact on prognosis and treatment in aml
-
2:04
the impact of cytogenetics on treatment decisions in aml
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
3:14
resistance mechanisms to flt3 inhibitors in aml
-
1:41
the importance of integrating genomic and cytogenetic data in treatment decisions for aml
-
3:28
bax-mediated bh3 mimetic resistance in aml
-
1:09:13
advancements in aml in atlantic canada
-
8:08
decision making on consolidation therapy for aml
-
1:14:27
major treatment decisions for patients with acute myeloid leukemia (aml)